Bharat Biotech Finishes Phase 2/3 Trials of Paediatric Covaxin
Bharat Biotech has finished the Phase 2/3 trials of the Covaxin for kids under 18 years of age and will submit the data by next...
Use UNICORN Signals App
By EquityPandit
